The CCO joined the meeting at 11am.
The CCO provided the Committee with an overview of his report.
Winter viruses
As a healthcare system, the HSE continues to manage an exceptional influenza season.
Pressures on unscheduled care
The CCO reported that a welcome decrease in attendances and admissions has been observedfollowing a sustained period of unprecedented unscheduled care activity. The National Crisis Management Team continues to meet to ensure that all required measures, including exceptional escalation actions and supports available through the Winter Plan 2022/23, are implemented to mitigate the impact of the continuing high levels of respiratory illness and the resultant pressures on hospitalisations and patient safety. The Chair, on behalf of the Committee, commended the work of frontline staff and management in handling the challenges of the past few weeks.
The Committee discussed the administration of IV antibiotics by nurses in residential settings and communities. The CCO agreed that an update would be provided on this item at the next committee meeting as part of his report.
The Committee also discussed the importance of learning from this winter. The CCO referred to a number of actions that are being progressed on this basis in order to plan for 2023/24.
The Committee discussed the importance of the ability to discharge patients to the community and how the challenges in recruitment and retention in home help potentially impact this.
The CCO noted that members of the National Crisis Management Team (NCMT) continue to visit Emergency Departments and acute hospitals to provide support and assistance with problem-solving to inform immediate actions and to share learnings to assist with long-term planning.
Autumn Vaccination Programme
NIAC have provided recommendations for a COVID vaccine booster for 18 – 49-year-olds, and the vaccination portal opened on December 29th. 67% of second booster vaccinations administered were to this age group in CVCs (23k between 29th Dec and 5th Jan). Due to the significant increase in newly approved groups (c. 1.48m 18–49-year-olds are now eligible), the percentage uptake has decreased from 49% to 31% as the denominator has become larger.
Streptococcus
The CCO provided the Committee with an update on Group A Streptococcus Surveillance in Ireland (as of January the 10th 2023). He informed the Committee that invasive Streptococcus is rare, and that in 2022, the numbers were not unusual, but that there was a greater surge in children having it. An update was provided in relation to the medicine working group of the IMT. The CCO advised that the group, composed of AMRIC and the HPRA, has been formed and that they have agreed the content and pathway for advising the system on currently available options for antibiotics.
National screening service (NSS)
Grace Turner, Head of Strategy, Business & Projects, joined the meeting
The Head of Strategy, Business & Projects, provided the Committee with an update on the National Screening Service Strategic Plan 2023 – 2027. The Committee’s feedback at the last meeting has been incorporated into the strategy. Achieving the objectives outlined in the Strategy will provide support and strong governance, quality assurance and continuous quality improvement, as well as supporting the achievement of strategic goals.
The Committee was informed that the Cervical Check service has resumed at the Coombe, noting that it will take time for the Coombe to grow into a principal laboratory. The Committee was given an update on Interval Cancer. The Cervical Check Interval Cancer Audit Implementation Group was established in December 2020. One of the key ERG report recommendations for action by this group was the establishment of patient-requested reviews. This review process is to begin shortly. The Legal Framework Group interim report outlined twelve recommendations regarding NSS, four of which require actions from the EMT and the Board. Following a discussion from the Committee about the recommendations, it was agreed to bring the recommendations to the Board.
The Chair suggested that it would be important to learn from women about the review process through an independent qualitative research project in 18 months-2 years’ time when a sufficient number of women have gone through the process.
National Womens and Infants Health Programme
A copy of the Neonatal Therapeutic Hypothermia in Ireland Report 2020 was shared with the Committee. The Report provides the aggregate data for all infants with Neonatal Encephalopathy (NE) requiring Therapeutic Hypothermia (TH) for the 5-year period 2016-2020.
National Cancer Care Programme (NCCP)
During the current winter pressure, acute oncology triage services are ensuring that patients can be assessed without attending ED. Where possible, patients who are being actively treated are being proactively contacted, given the concerns about non-presentation. Designated rooms for unscheduled assessments are working well, if at capacity in places. While patients may still need to go to ED if requiring admission, they will have already been assessed and have a management plan in place. Outsourcing to the private sector (or in-sourcing via overtime) is in use to address capacity challenges in radiation oncology. Elective surgical cancer treatments continue to be prioritised for admission, though challenges in securing beds remain.
Our Lady’s Hospital Navan (OLHN)
The CCO informed the Committee that seriously ill patients are being appropriately diverted by way of the ambulance protocol previously discussed by the Committee and the Board.
Cass Report on Transgender services
The CCO advised that Dr. Cass is due to meet with the HSE clinical team in February. The aim is to discuss the interim Cass Report and to share the findings with the HSE. A further update will be brought to the Committee at its next meeting.